🔎 Trials Near Me

ホーム › 結腸癌 › ミズーリ州

ミズーリ州における結腸癌の臨床試験

ミズーリ州内の拠点で、結腸癌に関する18件の研究が参加者を募集しています。

ミズーリ州内の都市

公式研究テキスト(英語)

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
  • Central Care Cancer Center - Bolivar, Bolivar
  • Cox Cancer Center Branson, Branson
  • 他23件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07283939

Family Communications After Genetic Testing

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
  • Central Care Cancer Center - Bolivar, Bolivar
  • Cox Cancer Center Branson, Branson
  • 他18件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07143487

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

  • Saint Luke's Cancer Institute ( Site 0082), Kansas City
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06997497

A Study of PHN-012 in Patients With Advanced Solid Tumors

  • PHN-012-001 Site, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07127874

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  • Missouri Cancer Associates, Columbia
  • Saint Luke'S Hospital of Kansas City, Kansas City
  • Midamerica Cancer Care, Kansas City
  • 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07284849

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women

  • Washington University School of Medicine, St Louis
被験者募集中観察研究
18歳〜50歳 · 女性 · 2026/09/02更新 · NCT06904365

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
  • Central Care Cancer Center - Bolivar, Bolivar
  • Cox Cancer Center Branson, Branson
  • 他14件
被験者募集中
45歳〜70歳 · 全性別 · 2026/09/02更新 · NCT05080673

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
  • Central Care Cancer Center - Bolivar, Bolivar
  • Cox Cancer Center Branson, Branson
  • 他25件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT05174169

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

  • Washington University School of Medicine, St Louis
被験者募集中
18歳以上 · 全性別 · 2026/07/14更新 · NCT06340646

Integrated Cancer Repository for Cancer Research

  • Saint Luke's Cancer Institute, East, Kansas City
  • Saint Luke's Cancer Institute, Kansas City
  • Saint Luke's Cancer Institute, Kansas City North, Kansas City
  • 他3件
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

  • Washington University, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT06051695

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

  • Missouri Cancer Associates, Columbia
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT07011576

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

  • Research Site, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/10更新 · NCT06835569

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Washington University Infusion Center Pharmacy, St Louis
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/05/27更新 · NCT03093116

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

  • Washington University School of Medicine, St Louis
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/02/20更新 · NCT04354064

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Kansas City
  • Massive Bio SYNERGY-AI site, St Louis
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

  • Washington University, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/09/09更新 · NCT06682793

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。